Showing results (141-150 of 147) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Journal of the Chinese Medical Association : JCMA|January 7, 2014
Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfaHsiang-Yu Lin, Yu-Hsiu Huang, Hsuan-Chieh Liao, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2008
Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in TaiwanJyh-You Liu, Hsi-Hsun Lin, Yung-Ching Liu, et al.Plos One|December 16, 2014
Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patientsJiann-Horng Yeh, Chun-Ta Huang, Chia-Hsiung Liu, et al.BMJ Open|July 19, 2013
Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A)Hsiang-Yu Lin, Hao-Chuan Liu, Yu-Hsiu Huang, et al.Science Translational Medicine|March 4, 2021
Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancerHeng-Hsiung Wu, Lung-Hung Tsai, Chun-Kai Huang, et al.Orphanet Journal of Rare Diseases|July 2, 2014
Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset Fabry mutation (IVS4 + 919G > A)Ting-Rong Hsu, Shih-Hsien Sung, Fu-Pang Chang, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|September 24, 2013
Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A)Hsuan-Chieh Liao, Yu-Hsiu Huang, Yann-Jang Chen, et al.Pageof 15